Cargando…
Clinical characteristics and outcomes of critically ill patients with acute COVID-19 with Epstein-Barr virus reactivation
BACKGROUND: Our goal is to further elucidate the clinical condition and prognosis of patients with severe acute COVID-19 with EBV reactivation. METHOD: This is a retrospective single-center study of COVID-19 patients admitted to the intensive care unit of Wuhan No. 3 Hospital (January 31 to March 27...
Autores principales: | Xie, Yun, Cao, Song, Dong, Hui, Lv, Hui, Teng, Xiaolei, Zhang, Jiaxiang, Wang, Tao, Zhang, Xiaoyan, Qin, Yun, Chai, Yujing, Yang, Luyu, Liu, Jun, Wang, Ruilan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441951/ https://www.ncbi.nlm.nih.gov/pubmed/34525962 http://dx.doi.org/10.1186/s12879-021-06638-y |
Ejemplares similares
-
Inhibition of Epstein-Barr virus reactivation by the flavonoid apigenin
por: Wu, Chung-Chun, et al.
Publicado: (2017) -
Stress-Induced Epstein-Barr Virus Reactivation
por: Sausen, Daniel G., et al.
Publicado: (2021) -
High incidence of Epstein–Barr virus, cytomegalovirus, and human-herpes virus-6 reactivations in critically ill patients with COVID-19
por: Simonnet, A., et al.
Publicado: (2021) -
Epstein-Barr Virus Reactivation Causing Cholestatic Hepatitis
por: Da Cunha, Teresa, et al.
Publicado: (2022) -
Variations of Epstein-Barr Virus Nuclear Antigen 1 in Epstein-Barr Virus-Associated Gastric Carcinomas from Guangzhou, Southern China
por: Chen, Jian-ning, et al.
Publicado: (2012)